Literature DB >> 21860573

Amblyopia and strabismus by monocular corneal opacity following suspected epidemic keratoconjunctivitis in infancy.

Byoungyoung Gu1, Junhyuk Son, Myungmi Kim.   

Abstract

PURPOSE: To identify the long term clinical course of amblyopia and strabismus that developed secondary to a monocular corneal opacity following suspected epidemic keratoconjunctivitis (EKC) in infancy.
METHODS: This was a retrospective study analyzing the medical records of seven patients, treated in our clinic, who were followed for more than five years.
RESULTS: Four patients in our clinic underwent a corneal ulcer treatment following suspected EKC. Each developed a monocular corneal opacity. Three patients with a chief complaint of corneal opacity were transferred to our clinic from other clinics. These patients had documented histories of treatment for EKC in infancy. All patients were treated with early occlusion therapy, but amblyopia persisted in four patients. Furthermore, all patients had strabismus and showed a significant reduction of stereoscopic vision.
CONCLUSIONS: Although infants with EKC are not always cooperative, slit lamp examination should be performed as early as possible, and appropriate medical treatment should be performed, thus reducing the development of corneal opacity. Careful follow up should be regularly performed, and the occurrence of amblyopia or strabismus should be verified at an early stage using visual acuity or ocular alignment examination. Ophthalmologic treatments, including active occlusion therapy, should also be pursued.

Entities:  

Keywords:  Amblyopia; Corneal opacity; Keratoconjunctivitis; Strabismus

Mesh:

Year:  2011        PMID: 21860573      PMCID: PMC3149137          DOI: 10.3341/kjo.2011.25.4.257

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  10 in total

1.  Comparative studies on aetiology and epidemiology of viral conjunctivitis in three countries of East Asia--Japan, Taiwan and South Korea.

Authors:  K Ishii; N Nakazono; K Fujinaga; S Fujii; M Kato; H Ohtsuka; K Aoki; C W Chen; C C Lin; M M Sheu
Journal:  Int J Epidemiol       Date:  1987-03       Impact factor: 7.196

2.  Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys.

Authors:  F E Fantes; K D Hanna; G O Waring; Y Pouliquen; K P Thompson; M Savoldelli
Journal:  Arch Ophthalmol       Date:  1990-05

3.  Corneal histology after epidemic keratoconjunctivitis.

Authors:  O E Lund; F H Stefani
Journal:  Arch Ophthalmol       Date:  1978-11

Review 4.  Factors involved in the production of amblyopia.

Authors:  G K Von Noorden
Journal:  Br J Ophthalmol       Date:  1974-03       Impact factor: 4.638

5.  Epidemic conjunctivitis in Germany, 2004.

Authors:  A Schrauder; D Altmann; G Laude; H Claus; K Wegner; R Köhler; H Habicht-Thomas; G Krause
Journal:  Euro Surveill       Date:  2006-07

6.  Confocal microscopy of subepithelial infiltrates occurring after epidemic keratoconjunctivitis.

Authors:  Adel H Alsuhaibani; John E Sutphin; Michael D Wagoner
Journal:  Cornea       Date:  2006-10       Impact factor: 2.651

7.  Amblyopia resulting from shield ulcers and plaques of the cornea in vernal keratoconjunctivitis.

Authors:  J A Cameron; P B Mullaney
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1997 Jul-Aug       Impact factor: 1.402

Review 8.  Herpes simplex virus keratitis in children.

Authors:  Eva-Marie Chong; Kirk R Wilhelmus; Alice Y Matoba; Dan B Jones; David K Coats; Evelyn A Paysse
Journal:  Am J Ophthalmol       Date:  2004-09       Impact factor: 5.258

9.  Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis.

Authors:  Sophie M Jones; Joel M Weinstein; Phillippa Cumberland; N Klein; Ken K Nischal
Journal:  Ophthalmology       Date:  2007-12       Impact factor: 12.079

10.  Herpes simplex keratitis and amblyopia.

Authors:  R G Beneish; F R Williams; R C Polomeno; M E Flanders
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1987 Mar-Apr       Impact factor: 1.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.